{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:57:23Z","timestamp":1792526243613,"version":"4.5.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,7,28]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>The use of terminal complement blockade is compatible with virus-specific T-cell (VST) expansion and clinical effectiveness. VST and complement-blocking agent concurrent therapy may be safely used in patients with thrombotic microangiopathy and viral infections.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020002252","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T15:36:46Z","timestamp":1595432206000},"page":"3252-3257","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1934-2954","authenticated-orcid":false,"given":"Jeremy D.","family":"Rubinstein","sequence":"first","affiliation":[{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH;"},{"name":"Division of Bone Marrow Transplantation and Immune Deficiency and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Experimental Hematology, Cancer and Blood Disease Institute, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Lutzko","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH;"},{"name":"Division of Experimental Hematology, Cancer and Blood Disease Institute, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Leemhuis","sequence":"additional","affiliation":[{"name":"Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Cancelas","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH;"},{"name":"Division of Experimental Hematology, Cancer and Blood Disease Institute, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonata","family":"Jodele","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH;"},{"name":"Division of Bone Marrow Transplantation and Immune Deficiency and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research, Children\u2019s National Health System, Washington, DC; and"},{"name":"Department of Pediatrics, The George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Hanley","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research, Children\u2019s National Health System, Washington, DC; and"},{"name":"Department of Pediatrics, The George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH;"},{"name":"Division of Bone Marrow Transplantation and Immune Deficiency and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2056-5167","authenticated-orcid":false,"given":"Michael S.","family":"Grimley","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH;"},{"name":"Division of Bone Marrow Transplantation and Immune Deficiency and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH;"},{"name":"Division of Bone Marrow Transplantation and Immune Deficiency and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"issue":"1","key":"2020072811262524900_B1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12109","article-title":"Immunity to viruses","volume":"255","author":"Braciale","year":"2013","journal-title":"Immunol Rev"},{"issue":"16","key":"2020072811262524900_B2","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2020072811262524900_B3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03256431","article-title":"Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients","volume":"16","author":"Breuer","year":"2012","journal-title":"Mol Diagn Ther"},{"issue":"8","key":"2020072811262524900_B4","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol Ther"},{"issue":"242","key":"2020072811262524900_B5","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"issue":"31","key":"2020072811262524900_B6","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"2020072811262524900_B7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/imr.12852","article-title":"Complement and human T cell metabolism: location, location, location","volume":"295","author":"West","year":"2020","journal-title":"Immunol Rev"},{"issue":"1","key":"2020072811262524900_B8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/imr.12472","article-title":"The \u201cins and outs\u201d of complement-driven immune responses","volume":"274","author":"Freeley","year":"2016","journal-title":"Immunol Rev"},{"issue":"12","key":"2020072811262524900_B9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"2020072811262524900_B10","article-title":"The natural history of BK polyomavirus and the host immune response after stem cell transplantation [published online ahead of print 18 December 2019]","author":"Laskin","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2020072811262524900_B11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajh.20068","article-title":"Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation","volume":"76","author":"Belford","year":"2004","journal-title":"Am J Hematol"},{"issue":"1","key":"2020072811262524900_B12","first-page":"71","article-title":"Fatal adenovirus infection indistinguishable from thrombotic microangiopathy after allogeneic CD34+ peripheral progenitor cell transplantation","volume":"30","author":"Yabe","year":"2005","journal-title":"Tokai J Exp Clin Med"},{"issue":"6","key":"2020072811262524900_B13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MCC.0000000000000657","article-title":"Acute kidney injury in hematopoietic stem cell transplantation","volume":"25","author":"Wanchoo","year":"2019","journal-title":"Curr Opin Crit Care"},{"issue":"11","key":"2020072811262524900_B14","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00467-017-3783-4","article-title":"Influenza-associated thrombotic microangiopathies","volume":"33","author":"Bitzan","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"13","key":"2020072811262524900_B15","first-page":"1049","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2020072811262524900_B16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/JVI.01689-07","article-title":"Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy","volume":"82","author":"Leen","year":"2008","journal-title":"J Virol"},{"issue":"2","key":"2020072811262524900_B17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbmt.2015.10.002","article-title":"Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020072811262524900_B18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/QCO.0000000000000456","article-title":"Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients","volume":"31","author":"Baugh","year":"2018","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"2020072811262524900_B19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bbmt.2016.03.032","article-title":"Terminal complement blockade after hematopoietic stem cell transplantation is safe without meningococcal vaccination","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6292","key":"2020072811262524900_B20","doi-asserted-by":"crossref","first-page":"aad1210","DOI":"10.1126\/science.aad1210","article-title":"T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells","volume":"352","author":"Arbore","year":"2016","journal-title":"Science"},{"issue":"6","key":"2020072811262524900_B21","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2020072811262524900_B22","doi-asserted-by":"crossref","first-page":"e64443","DOI":"10.1371\/journal.pone.0064443","article-title":"Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury","volume":"8","author":"Garcia","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"2020072811262524900_B23","doi-asserted-by":"crossref","first-page":"e01753","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"mBio"},{"issue":"10229","key":"2020072811262524900_B24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"2020072811262524900_B25","doi-asserted-by":"crossref","first-page":"ofaa105","DOI":"10.1093\/ofid\/ofaa105","article-title":"Coronavirus disease 2019 treatment: a review of early and emerging options","volume":"7","author":"McCreary","year":"2020","journal-title":"Open Forum Infect Dis"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/14\/3252\/1750304\/advancesadv2020002252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/14\/3252\/1750304\/advancesadv2020002252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T19:02:53Z","timestamp":1595962973000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/14\/3252\/461428\/Complement-inhibition-does-not-impair-the-clinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":25,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,7,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020002252","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]}}}